Effect of cyclosporine A on the binding
β
Kishor M. Wasan; Elizabeth M. Donnachie; David W. Seccombe; P. Haydn Pritchard
π
Article
π
2002
π
John Wiley and Sons
π
English
β 70 KB
The aim of this study was to elucidate the possible causes of elevated low-density lipoprotein (LDL)-cholesterol levels in patients with transplants who were treated with the immunosuppressant drug cyclosporine A (CSA). The binding and internalization of (125)I-LDL in the presence or absence of CSA